N6-Methyladenosine (M6A): A Promising New Molecular Target in Acute Myeloid Leukemia

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00251
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

RNA N6-Methyladenosine: A Promising Molecular Target in Metabolic Diseases

Cell and Bioscience
BiochemistryGeneticsMolecular Biology
2020English

New Molecular Markers in Acute Myeloid Leukemia

2011English

N6-Methyladenosine (M6A): Revisiting the Old With Focus on New, an Arabidopsis Thaliana Centered Review

Genes
Genetics
2018English

Cranberry A-Type Proanthocyanidins Selectively Target Acute Myeloid Leukemia Cells

Blood advances
Hematology
2019English

New Drugs Creating New Challenges in Acute Myeloid Leukemia

Genes Chromosomes and Cancer
Cancer ResearchGenetics
2019English

Molecular Emergence of Acute Myeloid Leukemia During Treatment for Acute Lymphoblastic Leukemia

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia

PLoS ONE
Multidisciplinary
2013English

Imidazoquinoxaline Derivative EAPB0503: A Promising Drug Targeting Mutant Nucleophosmin 1 in Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2017English

New Treatments and Strategies in Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy